• Home
  • 2.0 LPBI Executive Summary
  • 1.0 LPBI Executive Summary
  • Journal PharmaceuticalIntelligence.com
  • Portfolio of IP Assets
  • Knowledge PORTALS System (KPS)
  • 1.0 LPBI – 2012-2020 VISTA
  • LPBI Group’s History
  • 2.0 LPBI – 2021-2025 VISION
  • BioMed e-Series
  • Press Coverage
  • Investor Relations
  • Our TEAM
  • Founder
  • Funding, Deals & Partnerships
  • 1.0 LPBI Group News
  • 1.0 LPBI CALENDAR
  • 2.0 LPBI Group News
  • Testimonials about LPBI
  • DrugDiscovery @LPBI Group
  • Medical 3D Printing
  • e-VOICES Podcasting
  • LPBI Newsletters
  • Customer Surveys
  • Health Care INVESTOR’s Corner ($)
  • 2021 Summer Internship Portal
  • 2021-2025 Medical Text Analysis (NLP)
  • Artificial Intelligence: Genomics & Cancer
  • SOP Web STAT
  • Blockchain Transactions Network Ecosystem
  • Contact Us
  • 1.0 LPBI Brochure
  • 2.0 LPBI Brochure
  • 2.0 LPBI – Calendar of Zooms
  • Coronavirus, SARS-CoV-2 Portal
  • LPBI India
  • Synthetic Biology in Drug Discovery
  • Certificate One Year
  • NFT: Redefined Format of IP Assets
  • Audio English-Spanish: BioMed e-Series
  • Five Bilingual BioMed e-Series
  • Press Releases
  • Intangibles CIM
  • ChatGPT + Wolfram PlugIn
  • Medicine with GPT-4 & ChatGPT
  • BioMed Audio Podcast Library @LPBI Group

Leaders in Pharmaceutical Business Intelligence (LPBI) Group

Funding, Deals & Partnerships: BIOLOGICS & MEDICAL DEVICES; BioMed e-Series; Medicine and Life Sciences Scientific Journal – http://PharmaceuticalIntelligence.com

Feeds:
Posts
Comments

US Patents: Commercialization, Licensing or Sales Outright to Technology IP & Patents Funds

  • Commercialization of US Patents, Licensing or Sales Outright US Patents to Technology IP & Patents Funds

    Biologics, Small Molecules and Medical Devices US Patents

HQS – Boston, MA

HQS – Lausanne, Switzerland

  • Inventors: Biologics
  • Inventors: Medical Devices

OUR CURRENT PLAN FOR FUNDING GDE’s BUSINESS #4

  • 4.1, 4.2, 4.3, 4.4 are under discussion with one of our Investment Houses (Paris)
  • We need a similar Foundation to Melinda and Bill Gates that accept proposals for start ups in Biotech and Scientific Media for 4.5 and 4.6
  1. Commercialization of US Patents

4.1 (Dr. Pearlman – Cardiovascular and other Medical Devices) – 12 Patents before met Aviva, two joint concepts after met Aviva, on PPA on 3D Printing of Stents coated by EPCs and NO (Aviva has prior art.)

4.2 (Bill Zurn – Cardiovascular and other Medical Devices) US Patents before and after met Aviva

Any Development of MEMS and 3D Printing is UNDER GDE’s M3DP

4.3 (Dr. Nir, SBH Sciences – Cytokines)

Any development of Hydrogel and Cytikines using 3D BioPrinting is UNDER GDE’s M3DP

4.4 (Dr. Briggs – Biologics – cancer galactic-3 and Liver Fibrosis) needs investment

4.5 NEW (Dr. Codrington, Cambridge, UK) – Diagnostics, Antibodies in Hematology) – Candidate for Foundation Funding or M&A with Diagnostics Leader

4.6 NEW (Dr. Evelyna Cohn, Richmond, VA) – BioChemical Coating of Protective Equipment against RNA Viruses Epidemic  – Candidate fof Foundations or Public Governmental Funding Sources

Share this:

  • Click to share on Twitter (Opens in new window)
  • Click to share on LinkedIn (Opens in new window)
  • Click to share on Facebook (Opens in new window)
  • Click to print (Opens in new window)
  • Click to email a link to a friend (Opens in new window)

Like this:

Like Loading...

  • Follow Blog via Email

    Enter your email address to follow this blog and receive notifications of new posts by email.

    Join 9,319 other subscribers
  • Recent Posts

    • The Current Impact and Future of Technology within Cardiovascular Surgery September 23, 2023
    • The Continued Impact and Possibilities of AI in Medical and Pharmaceutical Industry Practices September 18, 2023
    • Regulatory T cells (Tregs) are important for sperm tolerance and male fertility September 11, 2023
    • ChatGPT Chemistry Assistant for Text Mining and the Prediction of metal–organic framework (MOF) synthesis August 27, 2023
    • Eight Subcellular Pathologies driving Chronic Metabolic Diseases – Methods for Mapping Bioelectronic Adjustable Measurements as potential new Therapeutics: Impact on Pharmaceuticals in Use August 19, 2023
    • ChatGPT Searches and Advent of Meta Threads: What it Means for Social Media and Science 3.0 July 11, 2023
    • OpenAI and ChatGPT face unique legal challenges over CopyRight Laws July 10, 2023
    • World Medical Innovation Forum, June 12 – June 14, 2023 The Westin Boston Seaport District organized by Mass General Brigham (MGB) June 25, 2023
    • Revolutionizing Business with Apple Vision Pro: The Ultimate Tool for Enhanced Visual Communication June 22, 2023
    • Optimism for Future Equality of Access to Healthcare in the Inaugural address as AMA President, Jesse M. Ehrenfeld, MD, MPH | AMA 2023 Annual Meeting of House of Delegates June 14, 2023
  • Archives

  • Categories

  • Meta

    • Log in
    • Entries feed
    • Comments feed
    • WordPress.org
    • 1 2012pharmaceutical
    • 1 Amandeep Kaur
    • 1 Aashir Awan, Phd
    • 1 Abhisar Anand
    • 1 Adina Hazan
    • 1 Alan F. Kaul, PharmD., MS, MBA, FCCP
    • 1 alexcrystal6
    • 1 anamikasarkar
    • 1 apreconasia
    • 1 aptubman
    • 1 Arav Gandhi
    • 1 aviralvatsa
    • 1 David Orchard-Webb, PhD
    • 1 danutdaagmailcom
    • 1 Demet Sag, Ph.D., CRA, GCP
    • 1 Dror Nir
    • 1 dsmolyar
    • 1 Ethan Coomber
    • 1 evelinacohn
    • 1 FrasonKalapurackal
    • 1 Gail S Thornton
    • 1 Irina Robu
    • 1 jayzmit48
    • 1 jdpmd
    • 1 jshertok
    • 1 kellyperlman
    • 1 Ed Kislauskis
    • 1 larryhbern
    • 1 Madison Davis
    • 1 marzankhan
    • 1 megbaker58
    • 1 ofermar2020
    • 1 Dr. Pati
    • 1 pkandala
    • 1 ritusaxena
    • 1 Rick Mandahl
    • 1 sjwilliamspa
    • 1 Srinivas Sriram
    • 1 stuartlpbi
    • 1 Dr. Sudipta Saha
    • 1 tildabarliya
    • 1 zraviv06
    • 1 zs22

Powered by WordPress.com.

WPThemes.


%d bloggers like this: